Phathom Pharmaceuticals (PHAT) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Phathom Pharmaceuticals (PHAT) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Phathom Pharmaceuticals

· PHAT

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

595.431 M

-3.01%

General

Market Cap: $595.43M
Enterprise Value: $557.41M
Shares Outstanding: 79,760,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 82.92%
Operating Margin: -16.96%
Net Profit Margin: -41.34%
FCF Margin: -15.32%
ROA: -30.29%
ROE: 25.70%
ROIC: -23.36%
Current Ratio: 1.92
Debt-to-Equity: -0.49
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 2.39
P/FCF: —
P/B: —
EV/EBITDA: -15.86

Growth

Rev 1Y: 216.93%
Rev 1Y Fwd Est: 80.51%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: $239.66M
Gross Margin: 82.92%
Operating Expenses: $239.37M
Operating Income: -$40.64M
Net Profit: -$99.07M

Balance Sheet

Cash and Equivalents: $182.48M
Working Capital: $142.14M
Total Assets: $327.08M
Net Debt: -$15.37M
Total Liabilities: $671.35M
Total Equity: -$344.27M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$36.69M
Cash Flow from Investing: -$219K
Cash Flow from Financing: $69.82M
Free Cash Flow: -$36.71M
Capital Expenditures: $17K